Smith & Nephew Plc
21 February 2003
21st February 2003
The Secretary
London Stock Exchange
RNS
Old Broad Street
London
EC2N 1HP
Dear Sirs,
Dealing by Director in Ordinary shares of Smith & Nephew plc
We have been informed today that Dr Rolf Stomberg, a director of Smith & Nephew
plc, acquired 32 Ordinary shares of the Company at 372.0 pence each on 3
December 2002, through the re-investment of the final dividend paid on 15
November 2002. Dr. Stomberg now has a beneficial interest in 6,945 Ordinary
shares being 0.00075% of the issued share capital of the Company.
Yours faithfully,
P.R. Chambers
Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.